Skip to main content
TipRanks
Go Ultimate75% OFF

Syros Pharmaceuticals (0LC7) Balance Sheet

1 Followers

Syros Pharmaceuticals Balance Sheet

Syros Pharmaceuticals's total assets for Q3 2024 were $85.00M, a decrease of 20.36% from the previous quarter. GB:0LC7 total liabilities were $96.12M for the fiscal quarter, a 15.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 23Dec 22Dec 21Dec 20Dec 19
$ 168.17M$ 244.49M$ 182.94M$ 213.25M$ 149.98M
$ 151.51M$ 116.75M$ 97.72M$ 122.70M$ 70.79M
$ 16.66M$ 127.74M$ 85.22M$ 90.55M$ 79.18M

Currency in USD

Syros Pharmaceuticals Liabilities to Assets

0100M200M300M0 %40 %80 %120 %LiabilitiesLiabilities to Assets2017201820192020202120222023AssetsLiabilitiesLiabilities to Assets